Biological pacemakers in canines exhibit positive chronotropic response to emotional arousal
Background
Biological pacemakers based on the HCN2 channel isoform respond to beta-adrenergic and muscarinic stimulation, suggesting a capacity to respond to autonomic input.
Objective
The purpose of this study was to investigate autonomic response to emotional arousal in canines implanted with murine HCN2-based biological pacemakers using gene therapy.
Methods
An electronic pacemaker was implanted with its lead in the right ventricular apical endocardium (VVI 35 bpm). An adenoviral HCN2/GFP construct (Ad-HCN2, n = 7) or saline (control, n = 5) was injected into the left bundle branch on day 2 after radiofrequency ablation of the atrioventricular node to induce complete atrioventricular block. Emotional arousal was achieved by presenting food following an overnight fast. Autonomic control was evaluated with Poincaré plots of R-RN against R-RN+1 intervals to characterize heart rate variability (HRV) and with continuous RR interval assessment via 24-hour ambulatory ECG. The 24-hour ECG and Poincaré plot shape were analyzed.
Results
During day 1 after biological pacemaker implantation, Poincaré HRV parameters and RR intervals were unchanged with food presentation. However, on day 7, food presentation was accompanied by an increase in HRV (SD1, p <0.07, and SD2, p <0.05) and shortening of RR interval (P <.05) in dogs with Ad-HCN2 but not in controls.
Conclusion
This is the first demonstration that biological pacemakers are capable of responding to natural arousal stimuli to elicit appropriate chronotropic responses, a potential advantage over electronic pacemakers.
Keywords: Biological pacemaker, Behavioral arousal, Food access denial, Gene therapy
Abbreviations: Ad-GFP, adenovirus expressing enhanced green fluorescent protein, Ad-HCN2, adenovirus expressing murine HCN2 (also refers to adenoviral construct mix of Ad-HCN2 and Ad-GFP), HRV, heart rate variability
To access this article, please choose from the options below
Drs. Cohen, Robinson, and Rosen have received grant funding from Boston Scientific, Inc. Gerard J.J. Boink received support from the Netherlands Heart Foundation (NHF) and the Interuniversity Cardiology Institute of the Netherlands (ICIN).
PII: S1547-5271(10)00794-0
doi:10.1016/j.hrthm.2010.08.004
© 2010 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
